The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid Eye Disease…

Thyroid Eye Disease, TEDGraves Orbitopathy

~Estimated

~$10 – $8,750

Sling Therapeutics, Inc.NCT07753603

Phase 2

A Multicenter, Extension Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

The overall study objective is to continue to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of linsitinib in subjects who were enrolled i…

Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more

~Estimated

~$10 – $8,750

Sling Therapeutics, Inc.NCT06112340